|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-705.60/--
|
企業價值
2.14M
|
資產負債 |
每股賬面淨值
-0.10
|
現金流量 |
現金流量率
--
|
損益表 |
收益
75.40K
|
每股收益
0.01
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/11 06:49 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generatedfrom contracts with customers in the United States. |